MOLECULAR ASPECTS OF CHEMICAL CARCINOGENESIS - THE ROLES OF ONCOGENES AND TUMOR-SUPPRESSOR GENES

被引:83
作者
STANLEY, LA
机构
[1] Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, Mansfield Road
关键词
TUMORIGENESIS; ONCOGENES; TUMOR SUPPRESSOR GENES; RAS ACTIVATION;
D O I
10.1016/0300-483X(94)02991-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The observation that oncogenes are frequently activated in human tumours raises the question of whether these genes are involved in chemical carcinogenesis. H-ras activation is probably an initiating event in mouse skin and rat mammary gland systems. The H-ras oncogene is also important in mouse liver tumours; in mouse lung the K-ras gene is commonly activated. In both, the mutations observed are usually those predicted from the adduct-forming properties of the carcinogen. Among non-ras oncogenes, only raf and neu have been detected in experimental tumours. Tumour suppressor genes are frequently inactivated in human tumours. Searches for such phenomena in animal tumours have generally had disappointing results. p53 and Rb gene alterations are rarely observed in chemically-induced tumours. The reason may be that unknown tumour suppressor genes are involved in animal tumour development. Several novel genes have been identified using animal tumour susceptibility models. Thus, ras genes are important in chemical carcinogenesis, but as the methodology for studying other genes improves, their roles will be seen in perspective.
引用
收藏
页码:173 / 194
页数:22
相关论文
共 50 条
  • [31] Impact of oncogenes and tumor suppressor genes on deregulation of hemostasis and angiogenesis in cancer
    Rak, J
    Klement, G
    CANCER AND METASTASIS REVIEWS, 2000, 19 (1-2) : 93 - 96
  • [33] Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor
    Sahu, Dinesh Kumar
    Singh, Neetu
    Das, Mumani
    Rawat, Jiledar
    Gupta, Devendra Kumar
    PEDIATRIC SURGERY INTERNATIONAL, 2022, 38 (11) : 1601 - 1617
  • [34] Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms’ tumor
    Dinesh Kumar Sahu
    Neetu Singh
    Mumani Das
    Jiledar Rawat
    Devendra Kumar Gupta
    Pediatric Surgery International, 2022, 38 : 1601 - 1617
  • [35] Evolutionary History of Oncogenes and Tumor Suppressor Genes Families: The Ancestral Origin in Mammals and Duplication Patterns
    Nawaz, Yasir
    Khan, Ali Zaib
    Tanvir, Fouzia
    Ambreen, Sadaf
    Zafar, Javaria
    Umar, Asma
    Majeed, Imran
    Tariq, Hamna
    LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (07) : 1226 - 1239
  • [36] Oncogenes and tumor suppressor genes in squamous cell carcinoma of the tongue in young patients
    Knopf, Andreas
    Lempart, Justine
    Bas, Murat
    Slotta-Huspenina, Julia
    Mansour, Naglaa
    Fritsche, Marie Kristin
    ONCOTARGET, 2015, 6 (05) : 3443 - 3451
  • [37] SEARCHING FOR TUMOR-SUPPRESSOR GENES - CHROMOSOMAL DELETIONS AND LOSS OF HETEROZYGOSITY IN HUMAN TUMORS
    BERGER, R
    BULLETIN DU CANCER, 1993, 80 (08) : 713 - 716
  • [38] The link between MHC class I abnormalities of tumors, oncogenes, tumor suppressor genes, and transcription factors
    Seliger, Barbara
    JOURNAL OF IMMUNOTOXICOLOGY, 2014, 11 (04) : 308 - 310
  • [39] Challenging Conventional Perceptions of Oncogenes and Tumor Suppressor Genes: A Comprehensive Analysis of Gene Expression Patterns in Cancer
    Zou, Mingyuan
    Qiu, Li
    Wu, Wentao
    Liu, Hui
    Xiao, Han
    Liu, Jun
    GENES CHROMOSOMES & CANCER, 2025, 64 (02)
  • [40] Aberrant expression of tumor suppressor genes and their association with chimeric oncogenes in pediatric acute lymphoblastic leukemia
    Kustanovich, AM
    Savitskaja, TV
    Bydanov, OI
    Belevtsev, MV
    Potapnev, MP
    LEUKEMIA RESEARCH, 2005, 29 (11) : 1271 - 1276